Literature DB >> 6099406

CT and MR for brain tumor implant therapy using CF-252 neutrons.

Y Maruyama, H W Chin, A B Young, J Beach, P Tibbs, S Goldstein, W Markesbery.   

Abstract

Magnetic resonance (MR) imaging of the brain allows very effective localization of tumor in brain, visualization of brain reaction to tumor, peritumoral edema, as well as destruction of normal anatomy and spread of tumor. MR readily imaged the brain in multiple views allowing three dimensional (3D) evaluation and more precise localization of tumor in the depths of the brain. It also assessed the extent of tumor infiltration away from the primary site. In an ongoing study of Cf-252 neutron brachytherapy of hemispheric malignant gliomas of the brain, we have found that the extent of tumor and the planning of the placement of multiple applicators in the brain for implant therapy was facilitated by both CT and MR scanning, but MR allowed better 3D localization, assessment of response and follow-up of tumor response. MR gave additional and different types of information about the tumor than CT scanning based upon proton distribution which greatly aided planning of tumor implant therapy and understanding of patterns of tumor response and recurrence after therapy.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6099406     DOI: 10.1007/bf00178118

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  12 in total

1.  Work in progress: 252Cf neutron brachytherapy for hemispheric malignant glioma.

Authors:  Y Maruyama; H W Chin; A B Young; J L Beach; J Bean; P Tibbs
Journal:  Radiology       Date:  1982-10       Impact factor: 11.105

2.  Proper analysis of clinical trials for malignant glioma.

Authors:  W Muir; H W Chin; A B Young; Y Maruyama
Journal:  Cancer Treat Rep       Date:  1982-01

3.  Survival response of malignant gliomas to radiotherapy with or without BCNU or methyl-CCNU chemotherapy at the University of Kentucky Medical Center.

Authors:  H W Chin; A B Young; Y Maruyama
Journal:  Cancer Treat Rep       Date:  1981 Jan-Feb

4.  Interstitial 252Cf neutron therapy for glioblastoma multiforme.

Authors:  Y Maruyama; H W Chin; A B Young; J Bean; P Tibbs; J L Beach
Journal:  Am J Clin Oncol       Date:  1982-12       Impact factor: 2.339

5.  Biological effects of Cf-252 neutrons at low dose rates.

Authors:  J M Feola; C A Nava; Y Maruyama
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1982-01

6.  Interstitial brachytherapy of primary brain tumors. Preliminary report.

Authors:  Y Hosobuchi; T L Phillips; T A Stupar; P H Gutin
Journal:  J Neurosurg       Date:  1980-11       Impact factor: 5.115

7.  Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery.

Authors:  M D Walker; S B Green; D P Byar; E Alexander; U Batzdorf; W H Brooks; W E Hunt; C S MacCarty; M S Mahaley; J Mealey; G Owens; J Ransohoff; J T Robertson; W R Shapiro; K R Smith; C B Wilson; T A Strike
Journal:  N Engl J Med       Date:  1980-12-04       Impact factor: 91.245

8.  Fast neutron beam radiotherapy of glioblastoma multiforme.

Authors:  R G Parker; H C Berry; A J Gerdes; M D Soronen; C M Shaw
Journal:  AJR Am J Roentgenol       Date:  1976-08       Impact factor: 3.959

Review 9.  A tumor/normal tissue advantage for low dose rate neutron brachytherapy.

Authors:  Y Maruyama; J M Feola; J L Beach
Journal:  Int J Radiat Oncol Biol Phys       Date:  1983-11       Impact factor: 7.038

Review 10.  Scheduling of hypoxic-tumor therapy using neutron brachytherapy.

Authors:  Y Maruyama; J L Beach; J Feola
Journal:  Radiology       Date:  1980-12       Impact factor: 11.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.